Finance

Lists
Why is CHCT down 3.79%?
Dive Deeper
CHCT:NYSE
Community Healthcare Trust Inc
$12.71
-3.79%
(-0.50) 1D
Oct 19, 12:58:16 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHCT...
Open
$13.19
High
$13.21
Low
$12.71
Mkt. cap
364.19M
Avg. vol.
354.15K
Volume
128.01K
Dividend
13.87%
Quarterly dividend
$0.44
Ex-dividend date
Aug 19, 2026
P/E ratio
19.12
52-wk high
$19.16
52-wk low
$12.71
EPS
$0.66
Beta
0.69
Shares outstanding
28.65M
No. of employees
35
Open
$13.19
High
$13.21
Low
$12.71
Mkt. cap
364.19M
Avg. vol.
354.15K
Volume
128.01K
Dividend
13.87%
Quarterly dividend
$0.44
Ex-dividend date
Aug 19, 2026
P/E ratio
19.12
52-wk high
$19.16
52-wk low
$12.71
EPS
$0.66
Beta
0.69
Shares outstanding
28.65M
No. of employees
35
News stories
From web sources and news partners
About Community Healthcare Trust Inc
CEO-
Employees35
Founded2014
Headquarters-
SectorReal estate investment trust
Websitechct.reit
Analyst ratings
Based on 3 analysts giving stock ratings to CHCT in the past 3 months
Buy
Buy
1
Hold
2
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for CHCT in the last 3 months.
Highest
Current $12.71
$17.00 (+33.75%)
Average
$16.00 (+25.89%)
Lowest
$14.00 (+10.15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alexander Goldfarb
Piper Sandler
Hold
Maintained
$14.00
+10.1%
10/12/2026
Michael Lewis
Truist Financial
Buy
Maintained
$17.00
+33.8%
10/09/2026
James Kammert
Evercore ISI
Hold
Maintained
$17.00
+33.8%
09/21/2026
Barry Oxford
Colliers Securities
Buy
Maintained
$20.00
+57.4%
02/18/2026
Last report
Aug 5, 2026
Fiscal period
Q2 2026
- / $0.11
Revenue / Est. (USD)
31.22M / 31.95M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
31.09M
30.95M
31.52M
31.22M
Cost of goods sold
5.93M
6.01M
6.37M
5.86M
Cost of revenue
5.93M
6.01M
6.37M
5.86M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.66M
8.06M
5.11M
4.89M
Operating expense
15.56M
18.87M
15.76M
15.63M
Total operating expenses
21.49M
24.89M
22.13M
21.49M
Operating income
9.60M
6.06M
9.39M
9.73M
Other non operating income
-
-
-
-
EBT including unusual items
1.64M
14.45M
2.55M
2.35M
EBT excluding unusual items
2.53M
-880.00K
2.59M
2.31M
Income tax expense
-
23.00K
-
-12.00K
Effective tax rate
-
0.16%
-
-0.51%
Other operating expenses
-
-
-
-
Net income
1.64M
14.43M
2.55M
2.36M
Net profit margin
5.28%
46.62%
8.08%
7.57%
Earnings per share
0.09
-
-
-
Interest and investment income
7.00K
19.00K
3.00K
3.00K
Interest expense
-7.08M
-6.96M
-6.80M
-7.43M
Net interest expenses
-7.07M
-6.94M
-6.80M
-7.42M
Depreciation and amortization charges
10.90M
10.81M
10.66M
10.74M
EBITDA
20.86M
17.30M
20.44M
20.87M
Gain or loss from assets sale
-
-
46.00K
-46.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps